Product Reports Resources Pricing Login Book a demo

CLEW

Biotech & Life Sciences · Netanya, Israel · Founded 2014

Predictive clinical analytics that ICU and high-acuity staff and management can use to avoid deteriorations MoreLess

CLEW is an analytics company operating in the HealthTech sector, providing an intelligent clinical surveillance platform for healthcare institutions. The firm was established in 2014 by co-founders Gal Salomon and Avigdor Faians in Netanya, Israel. Salomon’s motivation to create the company stemmed from a personal experience involving the loss of his mother due to what he perceived as an avoidable healthcare mistake, which drove him to develop a technological solution to prevent similar events. His background includes founding and leading Sansa Security until its acquisition by ARM, alongside roles at Pitango Venture Capital, Intel, and DSP Communications. Faians brings over two decades of experience in design management and system architecture from his time at companies like Mindspeed Technologies and Techtium.

The core of CLEW's business is a platform that uses artificial intelligence and machine learning models to anticipate patient deterioration, often hours before it would otherwise be detected. This system integrates clinical data from various sources, such as electronic health records (EHR) and bedside monitors, to create a consolidated, near real-time view of a patient's status. By providing predictive warnings, the technology enables care teams to intervene earlier, optimizing patient outcomes and resource allocation. The platform is designed for high-acuity settings within hospitals, including Intensive Care Units (ICUs), Emergency Departments (ED), and Post-Anesthesia Care Units (PACU). The business model centers on offering this AI-powered surveillance as a service to hospitals and healthcare systems, which helps them improve patient throughput and manage capacity more effectively. A significant milestone for the company was receiving FDA clearance in February 2021 for its AI-based predictive analytics technology for adult ICU patient assessment.

Keywords: clinical surveillance, predictive analytics, patient deterioration, artificial intelligence, machine learning, FDA-cleared, ICU management, hospital operations, real-time intelligence, clinical decision support, EHR integration, medical device data, resource allocation, patient throughput, length of stay reduction, high-acuity care, tele-ICU, sepsis detection, HealthTech, Gal Salomon

Valuation $0–100M
Revenue $1–10M
Headcount <100
Total funding $10–50M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for CLEW and the history behind them.

Talent graph

CLEW's talent

Book a demo to see the people
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

2 investors on CLEW's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 2 investors entered at this stage

Global footprint

Where CLEW has talent and traffic

Workforce by country
3 countries with
team presence
🇮🇱 Israel79%
🇺🇸 United States15.8%
🇩🇪 Germany5.3%
3 countries shown

Market sentiment

What the market is saying about CLEW

An AI-synthesized read of the highest-engagement posts about CLEW on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CLEW on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.